Assessing Cannabis Use in Cancer Treatment

IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer

Recruiting Observational Study
Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
450 (estimated)
Sponsor
State University of New York at Buffalo · Other
Who this trial is looking for

This trial is looking for adults with cancer who are receiving immunotherapy treatment. Participants will complete surveys about their symptoms and how they manage them, including the use of cannabis.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years old or older.
  • I have been diagnosed with cancer.
  • I am planning to use immunotherapy treatment.
  • I have pain but spend less than 50% of my time in bed or a chair.
  • I am fluent in English.

You may not be able to join if

  • I use synthetic cannabis or only use CBD.
  • I have not used cannabis in the past 3 months.
  • I am receiving immunosuppressants.
  • I am an organ transplant recipient.
  • I have been in hospice care in the past 6 months.
  • My pain limits my movement to more than 50% of my day in bed or a chair.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The purpose of this research is to assess how patients with cancer being treated with Immune Checkpoint Inhibitors (ICI) manage symptoms related to cancer and/or its treatment. Patients use a variety of ways to manage symptoms including traditional and alternative treatments including cannabis, acupuncture, etc. This research will have an important impact on our knowledge of cancer symptom managem…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * adult age of 18 years or older * cancer diagnosis and planning or using immunotherapy treatment, * pain and spend less than 50% in bed or chair * fluent in english language Exclusion Criteria: * use synthetic cannabis or only use Cannabidiol (CBD) * non users but used in the…
Contacts

Rebecca L Ashare, PhD

716-829-6273

rlashare@buffalo.edu

CONTACT

Colleen K Kilanowski, MS

716-829-5977

ckk@buffalo.edu

CONTACT